|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2016 |
|
Main ID: |
NCT02436538 |
|
Date of registration:
|
04/05/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Correlation Between Serum Anti-Müllerian Hormone & Müllerian Ducts Anomalies in Infertility
|
|
Scientific title:
|
Correlation Between Serum Anti-Müllerian Hormone (AMH) Levels & Müllerian Ducts Anomalies in Patients Undergoingintracytoplasmic Sperm Injection (ICSI) |
|
Date of first enrolment:
|
April 2015 |
|
Target sample size:
|
226 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02436538 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case-Only, Time Perspective: Retrospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Egypt
| | | | | | | |
|
Contacts
|
|
Name:
|
Yahia El-fassial, M.D |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
consultant |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- women with diagnosed mullerian anomlies whether clinically or through imaging
Exclusion Criteria:
- previous ovarian surgery
- ovarian drilling
- polycystic ovarian syndrome (PCOs).
Age minimum:
20 Years
Age maximum:
40 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Infertility
|
|
Intervention(s)
|
|
Other: Anti Mullerian hormone level; Mullerian duct anomaly type
|
|
Primary Outcome(s)
|
|
Correlation of serum anti-Müllerian hormone (AMH) level with mullerian anomalies
[Time Frame: 2 years]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|